Cargando…
Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients
OBJECTIVES: To estimate SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients and explore factors associated with delayed negative conversion. METHODS: A retrospective cohort study was conducted at the COVID-19 unit of a tertiary care center in the Western region of Saudi Arabia. Reverse...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254785/ https://www.ncbi.nlm.nih.gov/pubmed/35800556 http://dx.doi.org/10.4103/jfmpc.jfmpc_1841_21 |
_version_ | 1784740776414019584 |
---|---|
author | Aljunaid, Mohammed A. Albeshry, Abdulrahman M. Alshahrani, Najim Z. Barabie, Samaher S. |
author_facet | Aljunaid, Mohammed A. Albeshry, Abdulrahman M. Alshahrani, Najim Z. Barabie, Samaher S. |
author_sort | Aljunaid, Mohammed A. |
collection | PubMed |
description | OBJECTIVES: To estimate SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients and explore factors associated with delayed negative conversion. METHODS: A retrospective cohort study was conducted at the COVID-19 unit of a tertiary care center in the Western region of Saudi Arabia. Reverse transcriptase-polymerase chain reaction (RT-PCR) confirmed COVID-19 patients diagnosed between April 1 and June 30, 2020, were considered. The primary outcome was the time (days) from disease onset to first negative RT-PCR, which was analyzed using Kaplan–Meier and Cox regression survival methods. Demographic data, clinical history, baseline clinical, radiological and laboratory findings and management, and outcome data were collected and analyzed as factors associated with the viral RNA clearance time. RESULTS: One hundred and forty-four patients were included. The mean (standard deviation [SD]) age was 36.93 (14.41) years, 50.7% were females, and 45.1% were healthcare workers. COVID19 was asymptomatic, mild and moderate in 11.1%, 71.5% and 17.4% of the participants, respectively. Fever (59.4%) and cough (58.0%) were the dominant onset symptoms. The mean viral RNA clearance time was 22.9 days (SD = 8.6; 95% confidence interval [CI] = 21.5–24.3 days). Extended clearance time was associated with older age (mean = 24.0 vs. 22.0 days; log-rank = 0.037), married status (23.2 vs. 22.6 days; log-rank = 0.021), working in health sector (24.2 vs. 21.8 days; log-rank = 0.006), and having a chronic disease (24.8 vs. 21.9 days; log-rank = 0.028), compared to their counterparts, respectively. In the adjusted model, the job sector was the only factor that was independently associated with clearance time. Non-healthcare sector showed hazard ratio 1.8 (95% CI = 1.3–2.7; log-rank = 0.002) with reference to healthcare sector. CONCLUSION: SARS-CoV-2 RNA clearance time is likely to be longer in non-severe COVID-19 patients, representing an additional risk for the virus dissemination among the community and calling for higher caution among the population. |
format | Online Article Text |
id | pubmed-9254785 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-92547852022-07-06 Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients Aljunaid, Mohammed A. Albeshry, Abdulrahman M. Alshahrani, Najim Z. Barabie, Samaher S. J Family Med Prim Care Original Article OBJECTIVES: To estimate SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients and explore factors associated with delayed negative conversion. METHODS: A retrospective cohort study was conducted at the COVID-19 unit of a tertiary care center in the Western region of Saudi Arabia. Reverse transcriptase-polymerase chain reaction (RT-PCR) confirmed COVID-19 patients diagnosed between April 1 and June 30, 2020, were considered. The primary outcome was the time (days) from disease onset to first negative RT-PCR, which was analyzed using Kaplan–Meier and Cox regression survival methods. Demographic data, clinical history, baseline clinical, radiological and laboratory findings and management, and outcome data were collected and analyzed as factors associated with the viral RNA clearance time. RESULTS: One hundred and forty-four patients were included. The mean (standard deviation [SD]) age was 36.93 (14.41) years, 50.7% were females, and 45.1% were healthcare workers. COVID19 was asymptomatic, mild and moderate in 11.1%, 71.5% and 17.4% of the participants, respectively. Fever (59.4%) and cough (58.0%) were the dominant onset symptoms. The mean viral RNA clearance time was 22.9 days (SD = 8.6; 95% confidence interval [CI] = 21.5–24.3 days). Extended clearance time was associated with older age (mean = 24.0 vs. 22.0 days; log-rank = 0.037), married status (23.2 vs. 22.6 days; log-rank = 0.021), working in health sector (24.2 vs. 21.8 days; log-rank = 0.006), and having a chronic disease (24.8 vs. 21.9 days; log-rank = 0.028), compared to their counterparts, respectively. In the adjusted model, the job sector was the only factor that was independently associated with clearance time. Non-healthcare sector showed hazard ratio 1.8 (95% CI = 1.3–2.7; log-rank = 0.002) with reference to healthcare sector. CONCLUSION: SARS-CoV-2 RNA clearance time is likely to be longer in non-severe COVID-19 patients, representing an additional risk for the virus dissemination among the community and calling for higher caution among the population. Wolters Kluwer - Medknow 2022-05 2022-05-14 /pmc/articles/PMC9254785/ /pubmed/35800556 http://dx.doi.org/10.4103/jfmpc.jfmpc_1841_21 Text en Copyright: © 2022 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Aljunaid, Mohammed A. Albeshry, Abdulrahman M. Alshahrani, Najim Z. Barabie, Samaher S. Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients |
title | Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients |
title_full | Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients |
title_fullStr | Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients |
title_full_unstemmed | Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients |
title_short | Estimate and determinants of SARS-CoV-2 RNA clearance time among non-severe COVID-19 patients |
title_sort | estimate and determinants of sars-cov-2 rna clearance time among non-severe covid-19 patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254785/ https://www.ncbi.nlm.nih.gov/pubmed/35800556 http://dx.doi.org/10.4103/jfmpc.jfmpc_1841_21 |
work_keys_str_mv | AT aljunaidmohammeda estimateanddeterminantsofsarscov2rnaclearancetimeamongnonseverecovid19patients AT albeshryabdulrahmanm estimateanddeterminantsofsarscov2rnaclearancetimeamongnonseverecovid19patients AT alshahraninajimz estimateanddeterminantsofsarscov2rnaclearancetimeamongnonseverecovid19patients AT barabiesamahers estimateanddeterminantsofsarscov2rnaclearancetimeamongnonseverecovid19patients |